CC - The Chemours Company
13.25 0.00 (0.00%)
After hours: 4:30PM EDT
| Previous Close | 14.11 |
| Open | 14.20 |
| Bid | 13.15 x 1000 |
| Ask | 13.26 x 2900 |
| Day's Range | 13.16 - 14.48 |
| 52 Week Range | 11.71 - 46.13 |
| Volume | 4,564,586 |
| Avg. Volume | 3,177,920 |
| Market Cap | 2.166B |
| Beta (3Y Monthly) | 2.03 |
| PE Ratio (TTM) | 3.81 |
| EPS (TTM) | 3.48 |
| Earnings Date | Oct 30, 2019 - Nov 4, 2019 |
| Forward Dividend & Yield | 1.00 (7.66%) |
| Ex-Dividend Date | 2019-08-15 |
| 1y Target Est | 23.08 |
- Simply Wall St.
How Much Did The Chemours Company's (NYSE:CC) CEO Pocket Last Year?
In 2015 Mark Vergnano was appointed CEO of The Chemours Company (NYSE:CC). This analysis aims first to contrast CEO...
- ACCESSWIRE
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of The Chemours Company - CC
NEW YORK, NY / ACCESSWIRE / August 17, 2019 / Pomerantz LLP is investigating claims on behalf of investors of The Chemours Company (“Chemours” or the “Company”) (CC). Such investors are advised to contact Robert S. Willoughby at rswilloughby@pomlaw.com or 888-476-6529, ext. The investigation concerns whether Chemours and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.
- American City Business Journals
Philadelphia companies hit hard by sharp stock market declines
Among the Philadelphia region’s largest 20 publicly traded companies, the biggest losers were two chemical companies.
- InvestorPlace
10 Cheap Dividend Stocks to Load Up On
Although the market's near-7% setback suffered since its late-July high is neither devastating nor unusual, it has certainly been frustrating all the same. Many investors who were lured into the idea of "chasing performance" ended up being punished for doing so, even with Tuesday's bounce.The selloff isn't necessarily a reason to throw in the towel altogether though. Indeed, for income-minded investors willing to forego some excitement in the name of consistency will find the marketwide weakness has up-ended even some of the highest-quality dividend stocks. Many of these names can not only be purchased at below-average valuation, but at above-average yields. Your return on these cheap stocks to buy is based on your entry price. * 15 Growth Stocks to Buy for the Long Haul To that end, here's a rundown of ten dividend stocks to buy while the market's bearish tide has made them too cheap to ignore. They may not be at their absolute bottom yet, but they've given up far more ground than they ever should have been allowed to give up.InvestorPlace - Stock Market News, Stock Advice & Trading Tips Cheap Dividend Stocks to Buy: Pfizer (PFE)Source: Kojach Via FlickrDividend Yield: 3.96% Forward Price-to-Earnings Ratio: 12.6Pfizer (NYSE:PFE) can be considered cheap for one simple reason. That is, it's down nearly 20% year-to-date, reaching a 14-month low on Monday.The most recent portion of that weakness stems from the decision to sell its "off-patent" Upjohn division to rival drugmaker Mylan (NASDAQ:MYL), though clearly investors were losing interest -- and faith -- in PFE stock well before that announcement was made late last month. The expiration of key patents on blockbuster drug Lyrica has also weighed on investors' minds, as has a broad uncertainty over which piece of the healthcare market will bear the bulk of the burden for lowering costs.The doubters may have overshot their target though. Pfizer is now yielding 3.96%, and trades at only 12.6 times its (pre-spinoff) 2020 earnings. Chemours Co (CC)Source: Shutterstock Dividend Yield: 8% Forward P/E: 2.9The bulk of the recent weakness Chemours Co (NYSE:CC) shares have demonstrated reflects a potential legal liability related to its manufacture of perfluorochemicals (PFAs) which are used to make, among other things, Teflon cookware.The company's woes go well beyond that one stumbling block though. North America's titanium dioxide market is also running into a headwind, hitting Chemours in where it hurts the most. Its fiscal second-quarter titanium dioxide fell 35% year-over-year. * 10 Stocks Under $5 to Buy for Fall The worst-case scenario may well be fully priced in, however. Although this year is set to be a tough one, analysts are modeling an 11% turnaround in next year's revenue, prompting a sizeable recovery of this year's 52% earnings decline. The stock's yielding 8% in the meantime, on a dividend the company makes a point of paying if at all possible. AES (AES)Source: Shutterstock Dividend Yield: 3.6% Forward P/E: 10.6The second-quarter report from utility name AES (NYSE:AES) was anything but thrilling. Not only did income of 26 cents per share fall short of the 27 cents per share analysts were expecting, revenue was down a little more than 2%.The subsequent pullback added to an existing selloff. AES stock is now down nearly 17% from its March high, as the market seeks to right-price this otherwise reliable player in an unclear interest rate environment.For the most part, investors are forgetting that while it's not a high-growth vehicle, like most utility names, this one's rather well shielded from economic ebbs and flows that could disrupt its dividend … a dividend that has not failed to grow in any year since 2013. Molson Coors Brewing (TAP)Source: Drew Stephens via FlickrDividend Yield: 4.4% Forward P/E: 11.8For a handful of reasons, Molson Coors Brewing (NYSE:TAP) has been unable to restore its former greatness. The name behind not just Coors and Molson, but brands like Blue Moon, Ice House and Miller, just hasn't resonated with consumers like it did in the past. Beer drinkers are now opting for something else, particularly in the United States where it desperately needs to thrive. * 10 Real Estate Investments to Ride Out the Current Storm The full extent of the headwind may have already done all the damage it could do though. Next year's sales should essentially be flat, and the earnings decline is finally expected to abate; 2020's projected income of $4.48 per share is only a tiny fraction better than this year's likely bottom line of $4.45. But, that's enough (and then some) to fund the dividend going forward. It has only paid out $1.63 over the course of the past four quarters. The Carlyle Group (CG)Source: Shutterstock Dividend Yield: 6.5% Forward P/E: 8.7Technically speaking it's not a stock. Nevertheless, The Carlyle Group (NASDAQ:CG) has earned a spot on a list of cheap dividend stocks to buy because the yield of 6.5% is well above the market's average at this time. The S&P 500, for perspective, is yielding right around 1.9%.The Carlyle Group is usually categorized as an asset management outfit, although that's not quite what it does. The organization is a private equity and business-development player. It owns equity in, lends money to or outright owns smaller companies that may not otherwise be accessible to investors through a publicly-traded instrument.It's a structure that's ideal for dividend payments. Inasmuch as its portfolio of companies don't have public shareholders themselves, these businesses can be managed first and foremost with cash flow in mind. Seagate Technology (STX)Source: Shutterstock Dividend Yield: 5.6% Forward P/E: 9.3Much like its peer Micron Technology (NASDAQ:MU), in 2018 Seagate Technology (NASDAQ:STX) found itself to be a victim of a glut it helped create. With an exaggerated response to demand at the time, chip manufacturers ramped up their output of volatile memory (RAM) as well as data-storage drives that largely destroyed their pricing power.That glut finally appears to be abating. Although just barely, prices for NAND and DRAM have stopped falling, and have begun logging higher highs. * 7 Education Stocks to Buy for the Future of Academia Micron is certainly a bargain too, now that there's a light at the end of the tunnel. Seagate Technology is the better dividend name, however, yielding 5.6% and priced at less than ten times next year's expected earnings. Cardinal Health (CAH)Source: Via WikimediaDividend Yield: 4.4% Forward P/E: 8.6Cardinal Health (NYSE:CAH) is a supplier of all sorts of solutions to the healthcare industry. From pharmaceuticals to surgical supplies to services that help hospitals better manage operations like billing and reimbursement, the well-established company keeps caregivers in action.The non-cyclical nature of the business doesn't mean the company doesn't face competition and headwinds though. Indeed, CAH stock has been cut in half since its early 2015 high, reaching new multi-year lows last week. Its performance has been so bad, in fact, that frustrated shareholders are now prepping class-action suits.In the midst of that frenzied doubt is when CAH stock could be most trade-worthy, however. It just topped its quarterly-earnings expectations, earning $1.11 versus estimates of only 93 cents. And the pros are calling for an earnings rebound this year. AT&T (T)Source: Shutterstock Dividend Yield: 5.9% Forward P/E: 9.6AT&T (NYSE:T) took its eye off the ball in 2016. Admittedly, the long-belabored effort to acquire Time Warner was distracting, but the telecom giant's woes weren't just related to that difficult deal. Its DirecTV acquisition has created more problems than profit, and the company seemingly became complacent with its position as the No. 2 wireless provider in the United States.There's a reason T stock is up almost 30% from its late-December low, however, snapping out of a long-standing downtrend in the process. And, Time Warner isn't a core part of the bullish rationale. Investors are starting to realize what the advent of 5G could mean for the telecom market, and for AT&T in particular. * 10 Stocks Under $5 to Buy for Fall As Will Healy put it last week, "the 5G network that burdened the company for years may soon give AT&T a level of pricing power not seen since its days as a monopoly. Moreover, even if T stock stagnates in the near-term, investors can collect a generous, increasing dividend." Ryder System (R)Source: Shutterstock Dividend Yield: 4.4% Forward P/E: 8.3Most investors will recognize the name Ryder System (NYSE:R) as the company that rents moving vans and self-driven trucks to consumers, and that's certainly a key part of its business. The company is so much more than that, however. Ryder also arranges for long-term corporate leases of heavy haulers, offers fleet maintenance services and will even manage the delivery aspect of a supply chain for its customers.It's anything but a recession-proof business. And, with the economy seemingly slowing down against a backdrop of never-ending tariff chatter, R stock doesn't feel like the safest name to own.With a yield of 4.4% and the equally good chance that the global economy is going to be rekindled by an eventual end to the tariff war though, Ryder System is arguably too cheap to pass up at less than nine times next year's expected earnings. Citigroup (C)Source: Shutterstock Dividend Yield: 3.1% Forward P/E: 7.8Finally, add Citigroup (NYSE:C) to your list of dividend stocks to buy sooner rather than later.Yes, it certainly appears to be in the wrong place at the wrong time. Lower interest rates make the business of lending money less profitable by compressing the spread between its costs of capital and what it's able to charge borrowers. And, two weeks ago the big bank confirmed it … its reducing its base lending rate by a quarter of a percentage, from 5.5% to 5.25%. The move impacted all new loans made since Aug. 1.The assumptions about the depth of the impact may be overblown though. Even as he was explaining the rationale for last month's quarter-point rate cut, Federal Reserve Chairman Jerome Powell was already cautioning that the FOMC reserves the right to ramp up rates again if it sees any hint of unchecked inflation. Reading between the lines, it's a subtle clue that the Fed doesn't want to cut rates again when it will have a chance to in September. * 7 5G Stocks to Buy Now for the Future All the worst possible news may already be priced into C stock, and more.As of this writing, James Brumley held a long position in AT&T. You can learn more about James at his site, jamesbrumley.com, or follow him on Twitter, at @jbrumley. More From InvestorPlace * 2 Toxic Pot Stocks You Should Avoid * 10 Stocks Under $5 to Buy for Fall * 5 Stocks to Avoid Amid the Ongoing Trade War * 7 5G Stocks to Buy Now for the Future The post 10 Cheap Dividend Stocks to Load Up On appeared first on InvestorPlace.
- ACCESSWIRE
Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Chemours (CC)
NEW YORK, NY / ACCESSWIRE / August 8, 2019 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of The Chemours Company (“Chemours” or the “Company”) (NYSE:CC) ...
- Motley Fool
Here's Why Chemours Stock Fell 20.5% in July
Investors were anticipating weak second-quarter 2019 operating results. They were right.
Motley FoolThe Chemours Company (CC) Q2 2019 Earnings Call Transcript
CC earnings call for the period ending June 30, 2019.
- American City Business Journals
Local companies impacted by trade war-fueled stock market decline
Among the Philadelphia region’s largest 20 publicly traded companies, three in the chemical industry experienced the biggest dips in midday trading.
- Thomson Reuters StreetEvents
Edited Transcript of CC earnings conference call or presentation 2-Aug-19 12:30pm GMT
Q2 2019 Chemours Co Earnings Call
- PR Newswire
Chemours Acquires Mining Operations of Southern Ionics Minerals
WILMINGTON, Del., Aug. 2, 2019 /PRNewswire/ -- The Chemours Company (Chemours) (CC), a global chemistry company with leading market positions in titanium technologies, fluoroproducts and chemical solutions, today announced the acquisition of Southern Ionics Minerals, LLC (SIM), a minerals exploration, mining, and manufacturing company headquartered in Jacksonville, Florida. SIM was a wholly owned subsidiary of Southern Ionics Incorporated (SII), a privately held inorganic chemical manufacturer based in West Point, Mississippi. SIM mines and processes titanium and zirconium mineral sands from a similar geological formation as those produced by Chemours at the company's existing mineral sands mine in Florida.
- American City Business Journals
Chemours CEO addresses disappointing results
Chemours also announced a $25 million acquisition of a mineral mining and manufacturing firm in Florida.
- Zacks
Chemours' (CC) Earnings and Revenues Miss Estimates in Q2
Weak demand for Ti-Pure TiO2 and Illegal imports of HFC refrigerants hurt Chemours (CC) in Q2.
- Zacks
Chemours (CC) Q2 Earnings and Revenues Lag Estimates
Chemours (CC) delivered earnings and revenue surprises of -20.00% and -7.97%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?
- MarketWatch
Chemours stock falls after company's Q2 miss, lowered outlook
Chemours Co. shares fell more than 5% in the extended session Thursday after the chemical company spun off Dupont reported second-quarter results that missed expectations and lowered its outlook for the year, pinning it on its quarterly performance and "increasing macroeconomic uncertainty." Chemours said it earned $96 million, or 57 cents a share, in the quarter, compared with $1.53 a share in the year-ago quarter. Adjusted for one-time items, the company earned $120 million, or 72 cents a share, compared with $1.17 a share a year ago. Sales fell to $1.4 billion from $1.8 billion a year ago. Analysts polled by FactSet had expected adjusted earnings of 85 cents a share on sales of $1.5 billion. "The second quarter was challenging on a number of fronts, including softer than expected Ti-Pure demand and the continued impact of illegal imports of HFC refrigerants into Europe," Chemours Chief Executive Mark Vergnano said in a statement. The company said it expects adjusted EPS of between $2.37 and $3.08 a share for the year. "We are disappointed in having to reduce our guidance for 2019. However, as we look beyond the next two quarters, we remain confident in the growth prospects for each of our three core businesses," Vergnano said. Shares of Chemours had ended the regular trading day down 4.8%.
- PR Newswire
The Chemours Company Reports Second Quarter 2019 Results
Committed to Core Growth Strategy Despite Near Term Headwinds WILMINGTON, Del. , Aug. 1, 2019 /PRNewswire/ -- Second Quarter 2019 Highlights Net Sales of $1.4 billion Net Income of $96 million , with ...
- Benzinga
Q2 Earnings Outlook For Chemours
On Thursday, August 1, Chemours (NYSE: CC ) will report its last quarter's earnings. Here is Benzinga's preview of the company's release. Earnings and Revenue Wall Street analysts see Chemours reporting ...
- Barrons.com
Sizing Up an Environmental Liability for 3M and Others
PFAS, short for per- and polyfluoroalkyl substances, are a group of chemicals, manufactured in the U.S. from the 1940s through roughly the turn of the century, that can harm people’s health, according to the Environmental Protection Agency. States and municipalities are cleaning up sites involved in the manufacture of the chemicals, while governments are pursuing liability suits seeking money from producers. In the first quarter of 2019, 3M (ticker: MMM) took a $548 million charge for litigation, which it said included $235 million for lawsuits related to PFAS.
- PR Newswire
Chemours Announces Third Quarter Dividend
WILMINGTON, Del., July 31, 2019 /PRNewswire/ -- The Chemours Company (Chemours) (CC), a global chemistry company with leading market positions in titanium technologies, fluoroproducts and chemical solutions, announced today that the Board of Directors of Chemours declared a quarterly cash dividend of $0.25 per share on the company's common stock for the third quarter of 2019. The Chemours Company (CC) is a global leader in titanium technologies, fluoroproducts, and chemical solutions, providing its customers with solutions in a wide range of industries with market-defining products, application expertise and chemistry-based innovations. Chemours published its first corporate responsibility commitment report in 2018, which highlights goals aligned with the United Nations Sustainable Development Goals.
- Simply Wall St.
Is Chemours (NYSE:CC) A Risky Investment?
Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...
- Zacks
Chemours (CC) to Report Q2 Earnings: What's in the Cards?
Chemours (CC) is expected to see some pressure on Ti-Pure TiO2 volumes in Q2.
